Approximate Vial Duration At 200mcg Daily Approximately 50 administrations Approximately 10 weeks at 5 weekly administration At 300mcg Daily Approximately 33 administrations Approximately 67 weeks at 5 weekly administration At 500mcg Daily Approximately 20 administrations Approximately 4 weeks at 5 weekly administration At 1mg Daily Approximately 10 administrations Approximately 2 weeks at 5 weekly administration Commonly Investigated Research Areas Endogenous growth hormone release IGF-1 pathway signaling Recovery-focused physiological pathways Lean-body-composition research Sleep and recovery physiology Healthy-aging and regenerative research Important Handling Notes Use sterile needles and alcohol swabs Do not reuse or share needles Keep reconstituted peptide refrigerated at 28C Protect from excessive heat and direct sunlight For Research Use Only Not intended to diagnose, treat, cure, or prevent any disease
Mod-GRF (1-29) binds to GHRH receptors in the anterior pituitary gland, activating intracellular signalling cascades that increase cyclic AMP (cAMP) levels and calcium ion concentrations resulting in GH secretion
Studies on closely related cytokine receptors have demonstrated SFK activation for TPOR, EPOR, and PRLR upon ligand binding (114117)
By integrating injectable peptide therapy into your practice, you can elevate patient outcomes, expand your service offerings, and differentiate your business with regenerative, evidence-based treatments
According to the review by Petersenn, 2002, this is a 366-amino-acid, seven-transmembrane-domain G-protein-coupled receptor (7-TM GPCR)
